Related Experiment Video

Updated: Jun 25, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

[Thromboembolic risk in atrial fibrillation: new clinical perspectives]

Giovanni Quinto Villani1, Anna Maria Andreoli, Matteo Villani

  • 1Divisione di Cardiologia, Ospedale Civile "Guglielmo da Saliceto", Piacenza. gqvillani@hotmail.com

Giornale Italiano Di Cardiologia (2006)
|February 7, 2009
PubMed

Insights

Preventing embolic events in atrial fibrillation (AF) is crucial. This report compares risk stratification schemes for predicting thromboembolic risk in AF patients, aiding clinical decisions.

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Context:

  • Atrial fibrillation (AF) poses a significant risk for embolic complications, particularly ischemic stroke.
  • The elderly population experiences a disproportionately higher incidence of AF-related cerebrovascular accidents.
  • Oral anticoagulants like warfarin are effective but carry a hemorrhagic risk, especially in older adults.

Purpose:

  • To compare various risk stratification schemes for predicting thromboembolic risk in atrial fibrillation patients.
  • To discuss the clinical application and impact of these schemes on patient outcomes.

Summary:

  • Embolic stroke prevention is a primary goal in atrial fibrillation (AF) management.
  • While warfarin reduces ischemic stroke risk, its use is limited by safety concerns, especially in the elderly.
  • Existing risk stratification schemes for thromboembolic and hemorrhagic events in AF patients have limitations.

Impact:

  • This comparison aims to improve the clinical utility of risk stratification tools for AF patients.
  • Optimizing risk assessment can lead to more personalized and effective anticoagulation strategies.
  • Better prediction of thromboembolic events can reduce stroke incidence and improve patient prognosis.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...